Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-03

Clinical Trial Update: A Study to Determine the Effect of Nitroglycerin Ointment 0.4% (Cellegesic) on the Pain Associated With Chronic Anal Fissures [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated nitroglycerin ointment 0.4% (Cellegesic) for pain relief in chronic anal fissures; the study is completed and results were posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cellegesic (nitroglycerin ointment 0.4%)

Snippet

Sponsor: Forest Laboratories | Conditions: Fissure in Ano, Pain | Phase 3 | Status: COMPLETED | Results posted: 2016-11-03